It's not a COVID cure but study finds hydroxychloroquine may treat multiple sclerosis
Magazine
The Brighter Side of News flipped this story into The Brighter Side of News•131d
Related storyboards
Related articles
Biotech Start-Up Finds Overlooked Proteins That Could Cure Diseases
If you were under the impression that our genome had about 20,000 genes, each a recipe for a different protein, you’re not alone. The Human Genome …
Merck study results show blood cancer potential for new type of immunotherapy
For years, Merck & Co. has had an upper hand over its chief cancer drug competitor Bristol Myers Squibb. In March, however, Bristol Myers beat Merck …
Mirati matches Amgen with updated data for KRAS-blocking cancer drug
Mirati Therapeutics hopes to later this year win U.S. approval of only the second drug able to target tumors spurred by mutations in an elusive gene …
Diabetes Drug Metformin Disappoints in New Breast Cancer Treatment Trial
THURSDAY, May 26, 2022 (HealthDay News) -- A landmark clinical trial finds that a hoped-for treatment for early-stage breast cancer isn't the answer …
